GEN-011 PLANET Process: A Robust and Rapidly Scalable Manufacturing Process to Generate Neoantigen-targeted Peripheral T cells (NPTs)

Time: 4:30 pm
day: Day Two


– GEN-011 is an autologous, neoantigen-specific T cell therapy for the treatment of solid tumors
– GEN-011 is produced by the PLANET manufacturing process
– Review strategies and considerations to overcome manufacturing challenges associated with personalized therapy